[embeddoc url=”https://www.haemocare.org.ng/wp-content/uploads/2016/11/Camp-infusion-book-john2.pptx” viewer=”microsoft”]
“Treatment for all” means all people with bleeding disorders; including inhibitor patients, rare factor deficiencies and females should have access to safe and effective treatment.